Health-related quality of life and recovery capital among recovery residents taking medication for opioid use disorder in Texas.

EQ-5D-5L health-related quality of life medication for opioid use disorder opioid use disorder recovery capital recovery homes sober living homes

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 28 08 2023
accepted: 27 10 2023
medline: 7 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: epublish

Résumé

Recovery from opioid use disorder (OUD) includes improvements in health-related quality of life (HRQOL) and is supported by recovery capital (RC). Little is known about RC and HRQOL among recovery residents taking medication for OUD. We described HRQOL and RC and identified predictors of HRQOL. Project HOMES is an ongoing longitudinal study implemented in 14 recovery homes in Texas. This is a cross-sectional analysis of data from 358 participants' on HRQOL (five EQ-5D-5L dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and RC (Assessment of Recovery Capital scores) collected from April 2021 to June 2023. Statistical analyses were conducted using T-, Chi-squared, and Fisher's exact tests. Most participants were 35 years/older (50.7%), male (58.9%), non-Hispanic White (68.4%), heterosexual (82.8%), and reported HRQOL problems, mainly anxiety/depression (78.4%) and pain/discomfort (55.7%). Participants who were 35 years/older [mean (SD) = 42.6 (7.3)] were more likely to report mobility and pain/discomfort problems than younger participants. Female participants were more likely to report pain/discomfort problems than male participants. Sexual minorities were more likely to report anxiety/depression problems than heterosexual participants. Married participants and those in committed relationships were more likely to report problems conducting self-care than single/never-married participants. Comorbid conditions were associated with mobility, pain/discomfort, and usual activities problems. Most participants reported high social (65.4%), personal (69.0%), and total (65.6%) RC. Low personal RC was associated with mobility (aOR = 0.43, CI = 0.24-0.76), self-care (aOR = 0.13, CI = 0.04-0.41), usual activities (aOR = 0.25, CI = 0.11-0.57), pain/discomfort (aOR = 0.37, CI = 0.20-0.68), and anxiety/depression (aOR = 0.33, CI = 0.15-0.73) problems. Low total RC was associated with problems conducting self-care (aOR = 0.20, CI = 0.07-0.60), usual activities (aOR = 0.43, CI = 0.22-0.83), pain/discomfort problems (aOR = 0.55, CI = 0.34-0.90), and anxiety/depression (aOR = 0.20, CI = 0.10-0.41) problems. Social RC was not associated with HRQOL. Personal and total RC and comorbid conditions predict HRQOL. Although the opioid crisis and the increasing prevalence of comorbidities have been described as epidemics, they are currently being addressed as separate public health issues. Our findings underscore the importance of ensuring residents are provided with interprofessional care to reduce the burden of comorbidities, which can negatively impact their OUD recovery. Their RC should be routinely assessed and enhanced to support their recovery and improve HRQOL.

Sections du résumé

Background UNASSIGNED
Recovery from opioid use disorder (OUD) includes improvements in health-related quality of life (HRQOL) and is supported by recovery capital (RC). Little is known about RC and HRQOL among recovery residents taking medication for OUD. We described HRQOL and RC and identified predictors of HRQOL.
Methods UNASSIGNED
Project HOMES is an ongoing longitudinal study implemented in 14 recovery homes in Texas. This is a cross-sectional analysis of data from 358 participants' on HRQOL (five EQ-5D-5L dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and RC (Assessment of Recovery Capital scores) collected from April 2021 to June 2023. Statistical analyses were conducted using T-, Chi-squared, and Fisher's exact tests.
Results UNASSIGNED
Most participants were 35 years/older (50.7%), male (58.9%), non-Hispanic White (68.4%), heterosexual (82.8%), and reported HRQOL problems, mainly anxiety/depression (78.4%) and pain/discomfort (55.7%). Participants who were 35 years/older [mean (SD) = 42.6 (7.3)] were more likely to report mobility and pain/discomfort problems than younger participants. Female participants were more likely to report pain/discomfort problems than male participants. Sexual minorities were more likely to report anxiety/depression problems than heterosexual participants. Married participants and those in committed relationships were more likely to report problems conducting self-care than single/never-married participants. Comorbid conditions were associated with mobility, pain/discomfort, and usual activities problems. Most participants reported high social (65.4%), personal (69.0%), and total (65.6%) RC. Low personal RC was associated with mobility (aOR = 0.43, CI = 0.24-0.76), self-care (aOR = 0.13, CI = 0.04-0.41), usual activities (aOR = 0.25, CI = 0.11-0.57), pain/discomfort (aOR = 0.37, CI = 0.20-0.68), and anxiety/depression (aOR = 0.33, CI = 0.15-0.73) problems. Low total RC was associated with problems conducting self-care (aOR = 0.20, CI = 0.07-0.60), usual activities (aOR = 0.43, CI = 0.22-0.83), pain/discomfort problems (aOR = 0.55, CI = 0.34-0.90), and anxiety/depression (aOR = 0.20, CI = 0.10-0.41) problems. Social RC was not associated with HRQOL.
Conclusion UNASSIGNED
Personal and total RC and comorbid conditions predict HRQOL. Although the opioid crisis and the increasing prevalence of comorbidities have been described as epidemics, they are currently being addressed as separate public health issues. Our findings underscore the importance of ensuring residents are provided with interprofessional care to reduce the burden of comorbidities, which can negatively impact their OUD recovery. Their RC should be routinely assessed and enhanced to support their recovery and improve HRQOL.

Identifiants

pubmed: 38054070
doi: 10.3389/fpubh.2023.1284192
pmc: PMC10694473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1284192

Informations de copyright

Copyright © 2023 Obekpa, McCurdy, Schick, Markham, Gallardo and Wilkerson.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Stroke. 2006 Oct;37(10):2567-72
pubmed: 16946158
Drug Alcohol Depend. 2011 Nov 1;118(2-3):259-64
pubmed: 21546173
Alcohol Treat Q. 2006;24(1-2):33-73
pubmed: 16892161
Clin J Pain. 1999 Mar;15(1):31-40
pubmed: 10206565
ESC Heart Fail. 2022 Dec;9(6):3973-3984
pubmed: 35985663
Aging Clin Exp Res. 2002 Dec;14(6):499-508
pubmed: 12674491
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Alcohol Drug Educ. 2017 Apr;61(1):51-70
pubmed: 28757663
Addict Behav. 2017 Aug;71:25-30
pubmed: 28242532
Eur J Pain. 2018 Aug;22(7):1304-1311
pubmed: 29577509
MMWR Morb Mortal Wkly Rep. 2021 Dec 03;70(48):1655-1659
pubmed: 34855726
J Gen Intern Med. 2001 Apr;16(4):235-43
pubmed: 11318924
Med Care. 2017 Apr;55(4):336-341
pubmed: 28296674
Demography. 1995 Nov;32(4):483-507
pubmed: 8925942
Anesthesiol Clin. 2019 Sep;37(3):547-560
pubmed: 31337484
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
J Am Coll Cardiol. 2021 Jan 19;77(2):205-223
pubmed: 33446314
BMC Musculoskelet Disord. 2008 Jul 15;9:102
pubmed: 18627605
Psychol Bull. 2009 Jul;135(4):531-54
pubmed: 19586161
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
J Pain Res. 2018 Dec 06;11:3099-3108
pubmed: 30584352
Indian J Palliat Care. 2017 Oct-Dec;23(4):445-450
pubmed: 29123353
BMC Public Health. 2021 Nov 3;21(1):1990
pubmed: 34732156
J Subst Abuse Treat. 2014 Oct;47(4):293-8
pubmed: 25012552
Cureus. 2021 May 28;13(5):e15309
pubmed: 34221762
Value Health. 2023 Jun;26(6):796-801
pubmed: 36436793
J Drug Issues. 2020 Apr 01;51(2):253-267
pubmed: 34650312
Pain Med. 2019 Oct 1;20(10):1942-1947
pubmed: 30690594
Drug Alcohol Rev. 2012 May;31(3):334-41
pubmed: 21615809
J Subst Abuse Treat. 2022 Feb;133:108638
pubmed: 34657785
Drug Alcohol Rev. 2013 Mar;32(2):187-94
pubmed: 22882622
BMJ. 2015 Feb 13;350:h532
pubmed: 25680884
Can J Psychiatry. 2015 Feb;60(2 Suppl 1):S5-S15
pubmed: 25886672
J Am Geriatr Soc. 2018 Apr;66(4):693-698
pubmed: 29512120
Curr Opin Psychol. 2019 Dec;30:17-23
pubmed: 30711906
Drug Alcohol Depend. 2021 Nov 1;228:108996
pubmed: 34555691
Fam Pract. 2001 Jun;18(3):292-9
pubmed: 11356737
Drug Alcohol Depend. 2021 Apr 1;221:108584
pubmed: 33607497
J Addict Med. 2023 Nov-Dec 01;17(6):670-676
pubmed: 37934528
Arthritis Care Res (Hoboken). 2018 Feb;70(2):236-243
pubmed: 28589671
Drug Alcohol Depend. 2020 Oct 1;215:108221
pubmed: 32777692
Focus (Am Psychiatr Publ). 2021 Jul;19(3):294-302
pubmed: 34690595
Health Qual Life Outcomes. 2022 Feb 16;20(1):26
pubmed: 35172824
Drug Alcohol Depend. 2022 Sep 1;238:109551
pubmed: 35797876
Drug Alcohol Depend. 2019 Jun 1;199:122-128
pubmed: 31039486
Addict Sci Clin Pract. 2011 Jul;6(1):44-55
pubmed: 22003421
Prev Chronic Dis. 2019 Nov 27;16:E157
pubmed: 31775008
Front Hum Neurosci. 2022 Mar 03;16:736688
pubmed: 35308613
Subst Abuse Treat Prev Policy. 2015 Nov 11;10:45
pubmed: 26560076
Subst Abuse. 2022 Jun 27;16:11782218221103859
pubmed: 35783464
JAMA. 1998 Jul 8;280(2):147-51
pubmed: 9669787
J Subst Abuse Treat. 2017 May;76:88-93
pubmed: 28190543
Subst Abuse Treat Prev Policy. 2020 Sep 3;15(1):68
pubmed: 32883319
Subst Use Misuse. 2008;43(12-13):1971-86
pubmed: 19016174
Anesth Analg. 2017 Nov;125(5):1741-1748
pubmed: 29049118
Cureus. 2020 Oct 8;12(10):e10845
pubmed: 33178501
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):541-546
pubmed: 33857070
J Gen Intern Med. 2006 Mar;21(3):267-75
pubmed: 16336622
Mol Psychiatry. 2021 Jan;26(1):41-50
pubmed: 33188253
Adv Rheumatol. 2019 Nov 9;59(1):47
pubmed: 31706348
J Pain. 2010 Apr;11(4):312-20
pubmed: 19944648
PLOS Glob Public Health. 2022 Aug 22;2(8):e0000469
pubmed: 36962722
BMJ Open Respir Res. 2020 Mar;7(1):
pubmed: 32213535
J Addict Med. 2015 Jan-Feb;9(1):46-52
pubmed: 25325300
Br J Anaesth. 2013 Jul;111(1):52-8
pubmed: 23794645
J Couns Dev. 2022 Jun 08;:
pubmed: 35942199
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
J Stud Alcohol Suppl. 2005 Jul;(15):119-39; discussion 92-3
pubmed: 16223064
PLoS One. 2018 Jan 24;13(1):e0191334
pubmed: 29364938
J Gen Intern Med. 2016 May;31(5):486-91
pubmed: 26809204
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2597-607
pubmed: 23988582
Arch Phys Med Rehabil. 2015 Apr;96(4):569-77
pubmed: 25813889
Am J Addict. 2015 Jun;24(4):308-14
pubmed: 25808055
J Clin Psychol. 2011 Sep;67(9):942-68
pubmed: 21647882
J Public Health Manag Pract. 2019 Mar/Apr;25(2):E17-E24
pubmed: 29757813
Health Qual Life Outcomes. 2014 Aug 08;12:109
pubmed: 25104276
Alcohol. 2000 Aug;22(1):45-52
pubmed: 11109027
Am J Addict. 2010 Sep-Oct;19(5):409-15
pubmed: 20716303
J Pain. 2015 Aug;16(8):769-80
pubmed: 26028573

Auteurs

Elizabeth O Obekpa (EO)

Department of Health Promotion and Behavioral Science, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Sheryl A McCurdy (SA)

Department of Health Promotion and Behavioral Science, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Vanessa Schick (V)

Department of Management, Policy, and Community Health, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Christine M Markham (CM)

Department of Health Promotion and Behavioral Science, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Kathryn R Gallardo (KR)

Department of Health Promotion and Behavioral Science, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Johnny Michael Wilkerson (JM)

Department of Health Promotion and Behavioral Science, The University of Texas Health Science Center Houston, School of Public Health, Houston, TX, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH